ADC Therapeutics (ADCT) Treasury Shares (2019 - 2026)

ADC Therapeutics (ADCT) has reported Treasury Shares for 8 consecutive years, with $205000.0 the latest figure, recorded in Q1 2026.

• Quarterly Treasury Shares fell 0.97% year-over-year to $205000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205000.0 (down 0.97% YoY) and the FY2025 annual result came in at $205000.0, down 6.82% from the prior year.
• Treasury Shares was little changed at $205000.0 in Q1 2026 per ADCT's latest filing, from $205000.0 in the prior quarter.
• Over the last five years, Treasury Shares for ADCT reached as high as $9.1 million in Q1 2026 and fell as low as $2.6 million in Q4 2025.
• A 5-year average of $5.4 million and a median of $6.5 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares jumped 2875.0% — and 2024, when it tumbled 59.33%.
• Year by year, Treasury Shares stood at $679000.0 in 2022, then fell by 20.32% to $541000.0 in 2023, then slumped by 59.33% to $220000.0 in 2024, then decreased by 6.82% to $205000.0 in 2025, then changed by 0.0% to $205000.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $205000.0, $205000.0, and $205000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.